Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer

Ultrasound in Obstetrics and Gynecology

Volumn 34, Issue 3, 2009, Pages 335-344

  Testa, A C ^a,c   Ludovisi, M ^a   Manfredi, R ^b   Zannoni, G ^c   Gui, B ^c   Basso, D ^a   Di Legge, A ^a   Licameli, A ^a   Bidino, R D I ^d   Scambia, G ^a   Ferrandina, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Cervical cancer; Magnetic resonance; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; ULTRASONOGRAPHY; UTERINE CERVICAL NEOPLASMS;

EID: 69949099883     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.7325     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
2. Hoskins WJ, Perez CA, Young RC. Principles and Practice of Gynecologic Oncology. Lippincott Williams & Wilkins: Philadelphia, PA, 2000; 846-849.
3. Lagasse LD, Creasman W, Shingleton HM, Ford JH, Blessing J. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol 1980; 9: 90-98. (Pubitemid 10175950)
4. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathologic study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990; 38: 352-357. (Pubitemid 20362555)
5. Van Nagell JR, Roddick JW Jr, Lowin DM. The staging of cervical cancer: inevitable discrepancies between clinical staging and pathological findings. Am J Obstet Gynecol 1971; 110: 973-978.
6. Hricak H, Yu KK. Radiology in invasive cervical cancer. AJR Am J Roentgenol 1996; 167: 1101-1108.
7. Ferrandina G, Legge F, Fagotti A, Fanfani F, Distefano M, Morganti A, Cellini N, Scambia G. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. Gynecol Oncol 2007; 107: S127-S132. (Pubitemid 47483852)
8. D'Agostino G, Distefano M, Greggi S, Salerno M, Ferrandina G, Poerio A, Mancuso S, Scambia G. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin. Cancer Chemother Pharmacol 2002; 49: 256-260. (Pubitemid 34185600)
9. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 1988; 166: 623-631. (Pubitemid 18058914)
10. Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, Koelliker S, Siegelman ES, Brown JJ, McGhee RB Jr, Iyer R, Vitellas KM, Snyder B, Long HJ 3rd, Fiorica JV, Mitchell DG. American College of Radiology Imaging Network 6651; Gynecologic Oncology Group 183. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005; 36: 9329-9337.
11. Kim KH, Lee BH, Do YS, Chin SY, Park SY, Kim BG, Jang JJ. Stage IIB cervical carcinoma: MR evaluation of effect of intraarterial chemotherapy. Radiology 1994; 192: 61-65.
12. Manfredi R, Maresca G, Smaniotto D, Greggi S, Andrulli D, Rabitti C, Summaria V, Valentini AL, Panici PB, Cellini N, Marano P. Cervical cancer response to neoadjuvant therapy: MR imaging assessment. Radiology 1998; 209: 819-824. (Pubitemid 28564922)
13. Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, Giordano D, Scambia G, Marano P. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 2004; 231: 372-378. (Pubitemid 38552891)
14. Topal U, Punar S, Tasdelen I, Adim SB. Role of ultrasound-guided core needle biopsy of axillary lymph nodes in the initial staging of breast carcinoma. Eur J Radiol 2005; 56: 382-385. (Pubitemid 41659389)
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310. (Pubitemid 16134762)
16. Bland JM, Altman DG. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 2003; 22: 85-93.
17. Levenback C, Dershaw DD, Rubin SC. Endoluminal ultrasound staging of cervical cancer. Gynecol Oncol 1992; 46: 186-190.
18. Nam H, Park W, Huh SJ, Bae DS, Kim BG, Lee JH, Lee JW, Lim do H, Han Y, Park HC, Ahn YC. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol 2007; 107: 320-325. (Pubitemid 47575732)
19. Fischerova D, Cibula D, Stenhova H, Vondrichova H, Calda P, Zikan M, Freitag P, Slama J, Dundr P, Belacek J. Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. Int J Gynecol Cancer 2008; 18: 766-772. (Pubitemid 352020161)
20. Hawnaur JM, Johnson RJ, Carrington BM, Hunter RD. Predictive value of clinical examination, transrectal ultrasound and magnetic resonance imaging prior to radiotherapy in carcinoma of the cervix. Br J Radiol 1998; 71: 819-827.
21. Iwamoto K, Kigawa J, Minagawa Y, Miura H, Terakawa N. Transvaginal ultrasonographic diagnosis of bladder wall invasion in patients with cervical cancer. Obstet Gynecol 1994; 83: 217-219. (Pubitemid 24043291)
22. Kim SH, Han MC. Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging. AJR Am J Roentgenol 1997; 168: 393-397. (Pubitemid 27051971)
23. Sahdev A, Sohaib SA, Wenaden AE, Shepherd JH, Reznek RH. The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience. Int J Gynecol Cancer 2007; 17: 629-636. (Pubitemid 46743998)
24. Reinhardt MJ, Ehritt-Bruan C, Vogelgesang D, Ihling C, Högerle S, Mix M, Moser E, Krause TM. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001; 218: 776-782.
25. Ghi T, Giunchi S, Kuleva M, Santini D, Savelli L, Formelli G, Casadio P, Costa S, Meriggiola MC, Pelusi G. Three-dimensional transvaginal sonography in local staging of cervical carcinoma: description of a novel technique and preliminary results. Ultrasound Obstet Gynecol 2007; 30: 778-782. (Pubitemid 47612701)